Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Oliver & Co who wrote (2769)	11/16/1997 5:34:00 PM
From: BriBear	Read Replies (1) \| Respond to of 6136

Integrase inhibitor: ARNX is working on one... biz.yahoo.com Once the reverse transciptase enzyme has transposed HIV RNA into a DNA strand, integrase takes that strand & integrates it into the cellular DNA; then viral replication can begin. It seems to me that a down side to an integrase inhibitor is that it has a very narrow window to work within - after transcription & before integration. NRTIs & NonNRTIs stop the transcription process, PIs stop the assembly process of new virus particles. However, Aronex Pharmaceuticals (ARNX) has one entering Phase 2/3 trials soon & their price has been rising... Dr. Oliver: Do NonNRTIs work by binding with RT or as chain terminators?